Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiawei Xiaoyao Pill for menopausal syndrome
ChiCTR2200064974Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jul 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of jia wei xiao yao san and Xiangshao Granules in menopause (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: TCM syndrome integral table and Improved Kupperman Rating Scale in China. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
jia wei xiao yao sanXiangshao Granules
03
Conditions
menopause
Beyond the preview
Go deeper on ChiCTR2200064974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064974.